802TiP Immune tumor microenvironment (TME) in correlation with peripheral blood immune biomarkers as prognostic factor in metastatic renal cell carcinoma (mRCC) patients treated with nivolumab: The multicentric retrospective Meet-URO 18 study.

Saved in:
Bibliographic Details
Title: 802TiP Immune tumor microenvironment (TME) in correlation with peripheral blood immune biomarkers as prognostic factor in metastatic renal cell carcinoma (mRCC) patients treated with nivolumab: The multicentric retrospective Meet-URO 18 study.
Authors: Brunelli, M.1 (AUTHOR), Buti, S.2 (AUTHOR), Rebuzzi, S.E.3 (AUTHOR), Milella, M.4 (AUTHOR), Vellone, V.5 (AUTHOR), Bersanelli, M.2 (AUTHOR), Maruzzo, M.6 (AUTHOR), Basso, U.6 (AUTHOR), Signori, A.7 (AUTHOR), Martelli, V.3 (AUTHOR), Catalano, F.3 (AUTHOR), Damassi, A.8 (AUTHOR), Murianni, V.3 (AUTHOR), Merler, S.4 (AUTHOR), Casartelli, C.2 (AUTHOR), Fornarini, G.9 (AUTHOR)
Source: Annals of Oncology. 2020 Supplement 4, Vol. 31, pS607-S608. 2p.
Database: Academic Search Ultimate
Description
ISSN:09237534
DOI:10.1016/j.annonc.2020.08.2073